Chronic wound biofilms: Pathogenesis and potential therapies

Lab Medicine

Volumn 46, Issue 4, 2015, Pages 277-284

  Clinton, Allie ^a   Carter, Tammy ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Bacteria; Biofilms; Chronic wounds; Exopolysaccharide; Polymicrobial; Quorum sensing

Indexed keywords

ANTIBIOTIC SENSITIVITY; BACTERIAL VIRULENCE; BIOFILM; CHRONIC WOUND; NONHUMAN; PATHOGENESIS; QUORUM SENSING; REVIEW; CHRONIC DISEASE; HUMAN; MICROBIOLOGY; PATHOPHYSIOLOGY; WOUND INFECTION;

BACTERIAL POLYSACCHARIDE;

BIOFILMS; CHRONIC DISEASE; HUMANS; POLYSACCHARIDES, BACTERIAL; QUORUM SENSING; WOUND INFECTION;

EID: 84949782349     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LMBNSWKUI4JPN7SO     Document Type: Review

References (64)

1. Rondas AALM, Schols JMGA, Stobberingh EE, Halfens RJG. Prevalence of chronic wounds and structural quality indicators of chronic wound care in Dutch nursing homes. Int Wound J. 2013; e-pub ahead of print. doi: 10.1111/iwj.12172.
2. Driver VR, Blume PA. Evaluation of wound care and health-care use costs in patients with diabetic foot ulcers treated with negative pressure wound therapy versus advanced moist wound therapy. J Am Podiatr Med Assoc. 2014;104(2):147-153.
3. Trent JT, Falabella A, Eaglstein WH, Kirsner RS. Venous ulcers: pathophysiology and treatment options. Ostomy Wound Manage. 2005;51(5):38-54; quiz 55-56.
4. Kathju S, Nistico L, Hall-Stoodley L, Post JC, Ehrlich GD, Stoodley P. Chronic surgical site infection due to suture-associated polymicrobial biofilm. Surgic Infect (Larchmont). 2009;10(5):457-461.
5. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11 Suppl 1:S1-S28.
6. Spear M. The necessity of wound debridement. Plastic Surg Nurs. 2010;30(1):54-56.
7. Bertesteanu S, Triaridis S, Stankovic M, et al. Polymicrobial wound infections: pathophysiology and current therapeutic approaches. Int J Pharm. 2014;463(2):119-126.
8. Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS Suppl. 2013(136):1-58.
9. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair and Regen. 2008;16(1):37-44.
10. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318-1322.
11. Fuxman Bass JI, Russo DM, Gabelloni ML, et al. Extracellular DNA: a major proinflammatory component of Pseudomonas aeruginosa biofilms. J Immunol. 2010;184(11):6386-6395.
12. Watters C, Everett JA, Haley C, Clinton A, Rumbaugh KP. Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms. Infect Immun. 2014;82(1):92-100.
13. Costerton JW, Geesey GG, Cheng KJ. How bacteria stick. Sci Am. 1978;238(1):86-95.
14. Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu Rev Microbiol. 2002;56:187-209.
15. Flemming H-C, Neu TR, Wozniak DJ. The EPS matrix: the "house of biofilm cells". J Bacteriol. 2007;189(22):7945-7947.
16. O'Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Ann Rev Microbiol. 2000;54:49-79
17. Peterson LR. Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance. Clin Microbiol Infect. 2005;11 Suppl 5:4-16.
18. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett. 2004;230(1):13-18.
19. Fauvart M, De Groote VN, Michiels J. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J Med Microbiol. 2011;60(Pt 6):699-709.
20. Wolcott RD, Cox SB, Dowd SE. Healing and healing rates of chronic wounds in the age of molecular pathogen diagnostics. J Wound Care. 2010;19(7):272-278, 280-281.
21. Falanga V, Brem H, Ennis WJ, Wolcott R, Gould LJ, Ayello EA. Maintenance debridement in the treatment of difficult-to-heal chronic wounds. Recommendations of an expert panel. Ostomy Wound Manage. 2008;Suppl:2-13;quiz 14-15.
22. DeLeon S, Clinton A, Fowler H, Everett J, Horswill AR, Rumbaugh KP. Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model. Infect Immun. 2014;82:4718-4728.
23. Burmølle M, Webb JS, Rao D, Hansen LH, Sørensen SJ, Kjelleberg S. Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Appl Environ Microbiol. 2006;72(6):3916-3923.
24. Dalton T, Dowd SE, Wolcott RD, et al. An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PloS One. 2011;6(11):e27317. doi: 10.1371/journal.pone.0027317.
25. Keays T, Ferris W, Vandemheen KL, et al. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations. J Cyst Fibros. 2009;8(2):122-127.
26. James GA, Agostinho AM, Pulcini E de L. In vitro models for the growth and analysis of chronic wound biofilms. Adv Wound Care. 2010;1:293-298.
27. Molina-Manso D, del Prado G, Ortiz-Pérez A, et al. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections. Int J Antimicrob Agents. 2013;41(6):521-523.
28. Waters V, Ratjen F. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Cochrane Database Syst Rev. 2012;11:CD009528. doi: 10.1002/14651858.CD009528.pub2.
29. Pratten J, Ready D. Use of biofilm model systems to study antimicrobial susceptibility. Methods Mol Biol. 2010;642:203-215.
30. Santopolo L, Marchi E, Frediani L, Decorosi F, Viti C, Giovannetti L. A novel approach combining the Calgary Biofilm Device and Phenotype MicroArray for the characterization of the chemical sensitivity of bacterial biofilms. Biofouling. 2012;28(9):1023-1032.
31. Kim S, Kim MJ, Kang HY, Seol SY, Cho DT, Kim J. A simple colorimetric method for testing antimicrobial susceptibility of biofilmed bacteria. J Microbiol. 2010;48(5):709-711.
32. Schuster M, Lostroh CP, Ogi T, Greenberg EP. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J Bacteriol. 2003;185(7):2066-2079.
33. Taga ME, Semmelhack JL, Bassler BL. The LuxS-dependent autoinducer AI-2 controls the expression of an ABC transporter that functions in AI-2 uptake in Salmonella typhimurium. Mol Microbiol. 2001;42(3):777-793.
34. Li J, Attila C, Wang L, Wood TK, Valdes JJ, Bentley WE. Quorum sensing in Escherichia coli is signaled by AI-2/LsrR: effects on small RNA and biofilm architecture. J Bacteriol. 2007;189(16):6011-6020.
35. González Barrios AF, Zuo R, Hashimoto Y, Yang L, Bentley WE, Wood TK. Autoinducer 2 controls biofilm formation in Escherichia coli through a novel motility quorum-sensing regulator (MqsR, B3022). J Bacteriol. 2006;188(1):305-316.
36. Williams P. Quorum sensing, communication and cross-kingdom signalling in the bacterial world. Microbiology. 2007;153(Pt 12):3923-3938.
37. Bassler BL. How bacteria talk to each other: regulation of gene expression by quorum sensing. Curr Opin Microbiol. 1999;2(6):582-587.
38. Gjødsbøl K, Christensen JJ, Karlsmark T, Jørgensen B, Klein BM, Krogfelt KA. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J. 2006;3(3):225-231.
39. Miller MB, Bassler BL. Quorum sensing in bacteria. Ann Rev Microbiol. 2001;55:165-199.
40. Kessler E, Safrin M, Olson JC, Ohman DE. Secreted LasA of Pseudomonas aeruginosa is a staphylolytic protease. J Biol Chem. 1993;268(10):7503-7508.
41. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998;280(5361):295-298.
42. Whiteley M, Lee KM, Greenberg EP. Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 1999;96(24):13904-13909.
43. Tang HB, DiMango E, Bryan R, et al. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect Immun. 1996;64(1):37-43.
44. Rumbaugh KP, Griswold JA, Iglewski BH, Hamood AN. Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect Immun. 1999;67(11):5854-5862.
45. Otto M. Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu Rev Med. 2013;64:175-188.
46. Hammer BK, Bassler BL. Quorum sensing controls biofilm formation in Vibrio cholerae. Mol Microbiol. 2003;50(1):101-104.
47. Kalpana BJ, Aarthy S, Pandian SK. Antibiofilm activity of β-amylase from Bacillus subtilis S8-18 against biofilm forming human bacterial pathogens. Appl Biochem Biotechnol. 2012;167(6):1778-1794.
48. Kaplan JB. Therapeutic potential of biofilm-dispersing enzymes. Int J Artif Organs. 2009;32(9):545-554.
49. Gawande PV, Clinton AP, LoVetri K, Yakandawala N, Rumbaugh KP, Madhyastha S. Antibiofilm efficacy of DispersinB® wound spray used in combination with a silver wound dressing. Microbiol Insights. 2014;7:9-13.
50. Nijland R, Hall MJ, Burgess JG. Dispersal of biofilms by secreted, matrix degrading, bacterial DNase. PloS One. 2010;5(12):e15668. doi:10.1371/journal.pone.0015668.
51. Rogers SA, Huigens RW 3rd, Cavanagh J, Melander C. Synergistic effects between conventional antibiotics and 2-aminoimidazolederived antibiofilm agents. Antimicrob Agents Chemother. 2010;54(5):2112-2118.
52. Choi S-C, Zhang C, Moon S, Oh Y-S. Inhibitory effects of 4-hydroxy- 2, 5-dimethyl-3(2H)-furanone (HDMF) on acyl-homoserine lactonemediated virulence factor production and biofilm formation in Pseudomonas aeruginosa PAO1. J Microbiol. 2014;52:734-742.
53. He Z, Wang Q, Hu Y, et al. Use of the quorum sensing inhibitor furanone C-30 to interfere with biofilm formation by Streptococcus mutans and its luxS mutant strain. Int J Antimicrob Agents. 2012;40(1):30-35.
54. Vestby LK, Johannesen KCS, Witsø IL, et al. Synthetic brominated furanone F202 prevents biofilm formation by potentially human pathogenic Escherichia coli O103:H2 and Salmonella ser. Agona on abiotic surfaces. J Appl Microbiol. 2014;116:258-268.
55. Lönn-Stensrud J, Naemi A-O, Benneche T, Petersen FC, Scheie AA. Thiophenones inhibit Staphylococcus epidermidis biofilm formation at nontoxic concentrations. FEMS Immunol Med Microbiol. 2012;65(2):326-334.
56. Sully EK, Malachowa N, Elmore BO, et al. Selective chemical inhibition of agrquorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance. PLoS Pathog. 2014;10(6):e1004174. doi:10.1371/journal.ppat.1004174.
57. Research and Testing Laboratory. Microbial Diversity Analysis. 2014. Available at: http://www.researchandtesting.com/microbial-diversityanalysis. html. Accessed on: April 12, 2015.
58. Rhoads DD, Wolcott RD, Sun Y, Dowd SE. Comparison of culture and molecular identification of bacteria in chronic wounds. Int J Mol Sci. 2012;13(3):2535-2550.
59. Dowd SE, Wolcott RD, Kennedy J, Jones C, Cox SB. Molecular diagnostics and personalised medicine in wound care: assessment of outcomes. J Wound Care. 2011;20(5):232, 234-239.
60. Christensen GD, Simpson WA, Younger JJ, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985;22(6):996-1006.
61. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999;37(6):1771-1776.
62. Xu KD, Stewart PS, Xia F, Huang C-T, McFeters GA. Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl Environ Microbiol. 1998;64(10):4035-4039.
63. Sun Y, Dowd SE, Smith E, Rhoads DD, Wolcott RD. In vitro multispecies Lubbock chronic wound biofilm model. Wound Repair Regen. 2008;16(6):805-813.
64. Gilmore BF, Hamill TM, Jones DS, Gorman SP. Validation of the CDC biofilm reactor as a dynamic model for assessment of encrustation formation on urological device materials. J Biomed Mater Res B Appl Biomater. 2010;93B(1):128-140.